Why ARB, Guzman Y Gomez, Opthea, and Yancoal Shares Are Storming Higher
Why ARB, Guzman Y Gomez, Opthea, and Yancoal Shares Are Storming Higher
In afternoon trade, the $S&P/ASX 200 (.XJO.AU)$ is on course to record a decline. At the time of writing, the benchmark index is down 0.6% to 7,965.9 points.
下午交易時，該$S&P/ASX 200 (.XJO.AU)$ 目前正在錄得下降。撰寫時，基準指數下跌0.6%，至7,965.9點。
Four ASX shares that are not letting that hold them back today are listed below. Here's why they are rising:
以下四隻ASX股票今日漲幅強勁，詳情如下：
The ARB share price is up 6% to $42.21. This follows news that the 4×4 automotive parts manufacturer is increasing its presence in the United States. According to the release, its US based associate, ORW USA, has announced a conditional agreement to acquire the US-based 4 Wheel Parts business from Hoonigan for US$30 million. 4 Wheel Parts owns 42 retail stores and associated online stores. Should the acquisition proceed, ORW USA will settle the purchase using additional funding provided by its shareholders. This will see ARB increase its shareholding in ORW from 30% to 50%. ARB will separately acquire the Poison Spyder brand from Hoonigan for US$1 million.
ARb股價上漲6%，報42.21美元。這是因爲有消息稱，這家4×4汽車零部件製造商正在擴大其在美國的業務。據發佈的消息，其美國助理公司ORW USA宣佈達成條件協議，以3,000萬美元收購源自Hoonigan的美國4 Wheel Parts業務。4 Wheel Parts擁有42家零售店和相關的在線商店。如果收購順利進行，ORW USA將使用股東提供的額外基金來支付購買。這將使ARb將其在ORW的持股份額從30%增加到50%。ARb還將以價值100萬美元的價格單獨收購Poison Spyder品牌。
The Guzman Y Gomez share price is up 5% to $40.40. This has been driven by news that the quick service restaurant operator will be added to the ASX 200 index at the next quarterly rebalance. The company's shares are one of three that will join the benchmark index on 23 September. This is good news for two reasons. One is that its inclusion in a major index means that index funds have to buy shares to reflect the change. The second is that fund managers with strict investment mandates may now be free to invest in Guzman Y Gomez should they want to.
Guzman Y Gomez股價上漲5%，報40.40美元。這是由於快餐連鎖運營商即將在下一次季度再平衡時被納入ASX 200指數。該公司的股票將成爲23日加入基準指數的三家公司之一。這是個好消息，原因有二。一是其納入主要指數意味着指數基金必須買入股票以反映這一變化。二是隻要願意，有嚴格投資規定的基金經理現在可以自由投資於Guzman Y Gomez。
The Opthea share price is up 8.5% to 58 cents. This biopharmaceutical company's shares will be added to the ASX 300 index at the next rebalance later this month. This may have given its shares a boost today. In addition, the release of a corporate presentation may have caught the eye of investors. Opthea estimates that it has a $15 billion market opportunity for the VEGF-A Inhibitor it is developing.
Opthea股價上漲8.5%，報58美分。這家生物製藥公司的股票將在本月晚些時候的ASX 300指數再平衡時被納入。這可能是今天給其股票帶來提振的原因。此外，企業介紹資料的發佈可能引起了投資者的關注。Opthea估計其正在開發的VEGF-A抑制劑有150億美元的市場機會。
The Yancoal share price is up 4% to $5.50. This is another share rising thanks to its inclusion in the ASX 200 index at the quarterly rebalance. The coal miner's CEO, David Moult, was pleased with the news. He said: "We see the Company's inclusion in the S&P ASX indices providing a further opportunity to expand our investor base and bolster the trading liquidity of our shares."
澳洲煤炭股價上漲4%，達到5.50澳元。這是另一隻因其被納入ASX 200指數而上漲的股票，在季度重新平衡中。煤炭公司的CEO David Moult 對這個消息感到高興。他說：「我們認爲公司被納入S&P ASX指數將爲我們擴展投資者基礎和增加股票的交易流動性提供進一步機會。」